Release Date: 05/09/11 13:02 Summary: Interim Financial Report for Half Year Ended 30 June 2011 Price Sensitive: No Download Document 205.45KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%